KANNAPOLIS, N.C., Dec. 7, 2021–Salubrent Pharma Solutions is pleased to announce it is continuing to build upon its vision of becoming a full service, technology-focused CDMO by filling the positions of Director of Analytical Development and Analytical Development Chemist at the company’s recently opened cGMP analytical laboratory in Kannapolis, NC. Joining Salubrent are pharma industry veterans Anand Padmanabhan as Director of Analytical Development and Maggie Thomasson as Analytical Development Chemist.
“Adding these two seasoned experts to our team is representative of our commitment to providing the Salubrent Customer Experience to customers in need of comprehensive analytical testing services, including stability program management,” said Terry Novak, President & CEO of Salubrent Pharma Solutions. “The new hires allow Salubrent to fully utilize its new analytical lab and further extend the expertise, experience and capabilities that we bring to our customers.”
Mr. Padmanabhan brings over 29 years of experience with expertise in the Analytical R&D and Quality Control areas specializing in Analytical Method Development and Method Validation. He has contributed to many successful ANDA, and NDA filings and worked with a myriad of organizations including Glenmark Pharmaceuticals, G&W Laboratories, Ei LLC, and Applied Analytical Industries among others. Mr. Padmanabhan has a MS in Chemistry from NC A&T State University and a M.Sc. in Zoology from the University of Kerala, India.
Ms. Thomasson brings over five years of method development and validation experience with HPLC, MS, NMR, cell culture/lysis, and protein expression and a deep understanding of cGMP, GLP, CFR, AOAC, EHS, OSHA, and other safety and compliance guidelines and regulations. She has worked with Sentia Wellness and Pfizer (Aerotek). Ms. Thomasson earned her Analytical Chemistry PhD from Louisiana State University and is a chemistry graduate of the College of Charleston, SC.